MedPath

Does Adding Magnesium Sulphate to Low Dose Rocuronium Affects Depth of Blockade

Not Applicable
Completed
Conditions
Anesthesia
Interventions
Registration Number
NCT04510337
Lead Sponsor
National Cancer Institute, Egypt
Brief Summary

This study aim is to compare the effect of magnesium sulphate combined with low dose rocuronium versus standard dose rocuronium

Detailed Description

Comparing the effect of magnesium sulphate combined to low dose rocuronium versus standard dose rocuronium in cancer patients undergoing direct laryngoscopy for laryngeal tumors regarding intubating conditions, intraoperative relaxation, depth of anesthesia and recovery time.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients with Laryngeal tumors

ASA I-II

Age 30-70 years

Exclusion Criteria

Renal and or hepatic insufficiency

Neuromuscular disease

Large glottic and/or supra-glottic lesions with or without breathing difficulties

Known allergy to any of the used drug

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard rocuroniumstandard rocuronium dosepatients received rocuronium 0.6mg/kg
MagnesiumMagnesium sulfatepatients received 100 ml saline with 50mg/kg magnesium sulphate infusion over 10 minutes
Primary Outcome Measures
NameTimeMethod
Onset and duration of muscle relaxant90 minutes

Onset time of muscle relaxant and duration

Secondary Outcome Measures
NameTimeMethod
Degree of muscle relaxation90 minutes

depth of blockade

Trial Locations

Locations (1)

National Cancer Institute

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath